{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:03:29Z","timestamp":1789970609621,"version":"4.0.1"},"reference-count":10,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"Abstract<\/jats:title>\n \n Objectives<\/jats:title>\n Anti-thyroglobulin antibodies (TgAb) have a dual role during the follow-up of differentiated thyroid cancer (DTC): they may interfere with thyroglobulin (Tg) immunoassays and also serve as surrogate biomarkers of disease status. However, laboratory practices for TgAb measurement and reporting remain poorly standardised. We conducted an international survey to characterize current laboratory approaches and identify opportunities for harmonization.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A structured questionnaire was distributed to 120 laboratory medicine centres performing Tg and TgAb testing. The survey collected information on analytical platforms, TgAb reporting practices, positivity and interference thresholds, interference assessment strategies, and the interpretation of longitudinal TgAb changes. Results were analysed descriptively.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Fifty-one centres from six European countries participated (response rate, 42\u202f%). Most laboratories (88\u202f%) measured Tg and TgAb using assays from the same manufacturer. Marked heterogeneity was observed in quantitative TgAb reporting, definition of pathological TgAb concentrations, and thresholds considered indicative of potential Tg assay interference. Although more than half of the laboratories reported having defined an interference threshold, only two (4\u202f%) implemented and explicitly reported separate thresholds for thyroid autoimmunity and Tg assay interference. Structured interference investigations were uncommon (26\u202f%) and relied mainly on recovery testing, whereas predefined delta-check criteria for longitudinal TgAb interpretation were used by only 8\u202f% of centres.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Current laboratory practice for TgAb testing in DTC is highly heterogeneous and may contribute to inconsistent interpretation of Tg results. A dual-threshold reporting model that clearly distinguishes the diagnostic threshold for thyroid autoimmunity from the analytical threshold indicating potential Tg assay interference promote harmonization. Routine support for longitudinal TgAb interpretation, including serial trend reporting, represents an additional opportunity for laboratory specialists to enhance the management of patients with\u00a0DTC.<\/jats:p>\n <\/jats:sec>","DOI":"10.1515\/cclm-2026-1063","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:55:32Z","timestamp":1789970132000},"source":"Crossref","is-referenced-by-count":0,"title":["Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model"],"prefix":"10.1515","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-8206","authenticated-orcid":false,"given":"Eliane F.E.","family":"Wenstedt","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry , Erasmus MC University Medical Centre , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Migliardi","sequence":"additional","affiliation":[{"name":"European Ligand Assay Society (ELAS)-Italia , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-9648","authenticated-orcid":false,"given":"Ruggero","family":"Dittadi","sequence":"additional","affiliation":[{"name":"European Ligand Assay Society (ELAS)-Italia , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5937-7505","authenticated-orcid":false,"given":"Sjoerd A.A.","family":"Van Den Berg","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry , Erasmus MC University Medical Centre , Rotterdam , The Netherlands"},{"name":"Department of Internal Medicine , Erasmus MC University Medical Centre , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-1711","authenticated-orcid":false,"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[{"name":"Department of Medicine-DIMED , University of Padova , Padova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0230-0974","authenticated-orcid":false,"given":"Luca","family":"Giovanella","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Thyroid Centre Gruppo Ospedaliero Moncucco , Lugano , Switzerland"},{"name":"Nuclear Medicine and Thyroid Centre, University Hospital of Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026092105552719356_j_cclm-2026-1063_ref_001","doi-asserted-by":"crossref","unstructured":"Haugen, BR, Alexander, EK, Bible, KC, Doherty, GM, Mandel, SJ, Nikiforov, YE, et al.. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","DOI":"10.1089\/thy.2015.0020"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_002","doi-asserted-by":"crossref","unstructured":"Giovanella, L, D\u2019Aurizio, F, Algeciras-Schimnich, A, G\u00f6rges, R, Petra Petranovic Ovcaricek, P, Tuttle, RM, et al.. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. Eur J Endocrinol 2023;189:R11\u201327. https:\/\/doi.org\/10.1093\/ejendo\/lvad109.","DOI":"10.1093\/ejendo\/lvad109"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_003","doi-asserted-by":"crossref","unstructured":"Barbesino, G, Algeciras-Schimnich, A, Bornhorst, J. Thyroglobulin assay interferences: clinical usefulness of mass-spectrometry methods. J\u00a0Endocr Soc 2022;7:bvac169. https:\/\/doi.org\/10.1210\/jendso\/bvac169.","DOI":"10.1210\/jendso\/bvac169"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_004","doi-asserted-by":"crossref","unstructured":"Verburg, FA, Hartmann, D, Grelle, I, Giovanella, L, Buck, AK, Reiners, C, et al.. Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer. Horm Metab Res 2013;45:728\u201335. https:\/\/doi.org\/10.1055\/s-0033-1349890.","DOI":"10.1055\/s-0033-1349890"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_005","doi-asserted-by":"crossref","unstructured":"Giovanella, L, Feldt-Rasmussen, U, Verburg, FA, Grebe, SK, Plebani, M, Clark, PM, et al.. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges. Clin Chem Lab Med 2015;53:1301\u201314. https:\/\/doi.org\/10.1515\/cclm-2014-0813.","DOI":"10.1515\/cclm-2014-0813"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_006","doi-asserted-by":"crossref","unstructured":"Wenstedt, EFE, Hillebrand, JJ, Dik, WA, Judith, BJAP, Van Den Berg, SAA. Differences in laboratory reporting of thyroglobulin antibody positivity\u00a0\u2013\u00a0a national survey across laboratories in the Netherlands. Clin Chem Lab Med 2026;64:e182\u20134. https:\/\/doi.org\/10.1515\/cclm-2026-0056.","DOI":"10.1515\/cclm-2026-0056"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_007","doi-asserted-by":"crossref","unstructured":"Verburg, FA, Luster, M, Cupini, C, Chiovato, L, Duntas, L, Elisei, R, et al.. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position paper. Thyroid 2013;23:1211\u201325. https:\/\/doi.org\/10.1089\/thy.2012.0606.","DOI":"10.1089\/thy.2012.0606"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_008","doi-asserted-by":"crossref","unstructured":"Giovanella, L, Clark, PM, Chiovato, L, Duntas, L, Elisei, R, Feldt-Rasmussen, U, et al.. Diagnosis of endocrine disease: thyroglobulin measurement using highly-sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. Eur J Endocrinol 2014;171:R33\u201346. https:\/\/doi.org\/10.1530\/eje-14-0148.","DOI":"10.1530\/EJE-14-0148"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_009","doi-asserted-by":"crossref","unstructured":"Giovanella, L, Verburg, FA, Trimboli, P, Imperiali, M, Keller, F, Ceriani, L, et al.. Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor \u00ae Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma. Clin Chem Lab Med 2019;57:1185\u201391. https:\/\/doi.org\/10.1515\/cclm-2018-1390.","DOI":"10.1515\/cclm-2018-1390"},{"key":"2026092105552719356_j_cclm-2026-1063_ref_010","doi-asserted-by":"crossref","unstructured":"Azmat, U, Porter, K, Senter, L, Ringel, MD, Nabhan, F. Thyroglobulin liquid chromatography-tandem mass spectrometry has a low sensitivity for detecting structural disease in patients with antithyroglobulin antibodies. Thyroid 2017;27:74\u201380. https:\/\/doi.org\/10.1089\/thy.2016.0210.","DOI":"10.1089\/thy.2016.0210"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1063\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:55:38Z","timestamp":1789970138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1063\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":10,"alternative-id":["10.1515\/cclm-2026-1063"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-1063","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}